ArticleIranian journal of cancer prevention2014

In Silico Design and Analysis of TGFαL3-SEB Fusion Protein as "a New Antitumor Agent" Candidate by Ligand-Targeted Superantigens Technique.

Abbas Ali Imani-Fooladi et al.PubMed ↗Full text ↗

No numbers read from the abstract.